Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
暂无分享,去创建一个
R. Rudick | B. Trapp | J. Peterson | R. Fox | K. Mirnics | Ranjan Dutta | W. Macklin | A. Chang | David A. Lewis | T. Gudz | Ansi Chang | Richard Rudick | Bruce D. Trapp | John Peterson | Karoly Mirnics | Xinghua Yin | Ranjan Dutta | Jennifer McDonough | Thalia Torres | Tatyana Gudz | Wendy B. Macklin | Robert J. Fox | J. McDonough | Xinghua Yin | D. Lewis | T. Torres | R. Dutta | Ansi Chang
[1] Peter K. Stys,et al. General mechanisms of axonal damage and its prevention , 2005, Journal of the Neurological Sciences.
[2] Ilana S. Hairston,et al. Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice , 2005, Cell.
[3] K. Mirnics,et al. Presenilin-1-Dependent Transcriptome Changes , 2005, The Journal of Neuroscience.
[4] Stephen G Waxman,et al. Na+ channel expression along axons in multiple sclerosis and its models. , 2004, Trends in pharmacological sciences.
[5] J. Wilusz,et al. Bringing the role of mRNA decay in the control of gene expression into focus. , 2004, Trends in genetics : TIG.
[6] A. Lo,et al. Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI , 2004, Experimental Neurology.
[7] Ludwig Kappos,et al. Multiple sclerosis as a generalized CNS disease—comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS , 2004, Journal of Neuroimmunology.
[8] Jia Newcombe,et al. Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] D. Bechtold,et al. Axonal protection using flecainide in experimental autoimmune encephalomyelitis , 2004, Annals of neurology.
[10] Michael A. Beer,et al. Predicting Gene Expression from Sequence , 2004, Cell.
[11] P. Stys. White matter injury mechanisms. , 2004, Current molecular medicine.
[12] F. Zipp,et al. Activation of Microglial Poly(ADP-Ribose)-Polymerase-1 by Cholesterol Breakdown Products during Neuroinflammation , 2003, The Journal of experimental medicine.
[13] L. Griffiths,et al. Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. , 2003, Brain research. Molecular brain research.
[14] R. Reynolds,et al. Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult , 2003, Brain pathology.
[15] Douglas A. Hosack,et al. Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.
[16] A. Sampson,et al. Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.
[17] J. Fritschy,et al. Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. , 2003, Pharmacology & therapeutics.
[18] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[19] M. Brunori,et al. Nitric oxide and cytochrome oxidase: reaction mechanisms from the enzyme to the cell. , 2003, Free radical biology & medicine.
[20] Kenneth J. Smith,et al. Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration , 2003, Annals of neurology.
[21] H. Bading,et al. The Yin and Yang of NMDA receptor signalling , 2003, Trends in Neurosciences.
[22] Ulf Ziemann,et al. Rapid modulation of GABA in sensorimotor cortex induced by acute deafferentation , 2002, Annals of neurology.
[23] W. Sieghart,et al. Homologous sites of GABAA receptor α1, β3 and γ2 subunits are important for assembly , 2002, Neuropharmacology.
[24] P. Stys,et al. Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons , 2002, Neuroscience Letters.
[25] H. Bading,et al. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways , 2002, Nature Neuroscience.
[26] Jorge R. Oksenberg,et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.
[27] W. Sieghart,et al. Homologous sites of GABA(A) receptor alpha(1), beta(3) and gamma(2) subunits are important for assembly. , 2002, Neuropharmacology.
[28] Jason E. Stewart,et al. Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.
[29] B. Trapp,et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.
[30] D. Colman,et al. Organizing Principles of the Axoglial Apparatus , 2001, Neuron.
[31] B. J. Hanson,et al. Human Complex I Defects Can Be Resolved by Monoclonal Antibody Analysis into Distinct Subunit Assembly Patterns* , 2001, The Journal of Biological Chemistry.
[32] D. Turnbull,et al. Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. , 2001, Methods in cell biology.
[33] R. Rudick,et al. Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients , 2000, Annals of neurology.
[34] Adelbert Ames,et al. CNS energy metabolism as related to function , 2000, Brain Research Reviews.
[35] Pat Levitt,et al. Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.
[36] S. Croul,et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis , 2000, Journal of the Neurological Sciences.
[37] P. Stys,et al. Calpain Inhibitors Confer Biochemical, but Not Electrophysiological, Protection Against Anoxia in Rat Optic Nerves , 2000, Journal of neurochemistry.
[38] M. Blinkenberg,et al. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS , 2000, Neurology.
[39] J. Trent,et al. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays , 1999 .
[40] R. Herndon,et al. Selecting relapsing remitting multiple sclerosis patients for treatment: the case for early treatment , 1999, Journal of Neuroimmunology.
[41] N. Brandon,et al. GABAA-receptor-associated protein links GABAA receptors and the cytoskeleton , 1999, Nature.
[42] R. Rudick,et al. Neurodegeneration in Multiple Sclerosis: Relationship to Neurological Disability , 1999 .
[43] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[44] E. Salmon,et al. How calcium causes microtubule depolymerization. , 1997, Cell motility and the cytoskeleton.
[45] T. Dawson,et al. Neurobiology of nitric oxide. , 1996, Critical reviews in neurobiology.
[46] M. Wong-Riley,et al. Disproportionate regulation of nuclear- and mitochondrial-encoded cytochrome oxidase subunit proteins by functional activity in neurons , 1995, Neuroscience.
[47] G. Kreutzberg,et al. Microglia: Intrinsic immuneffector cell of the brain , 1995, Brain Research Reviews.
[48] C. Hoppel,et al. Decreased activities of ubiquinol:ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c:oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin[c-lactam]-induced methylmalonic aciduria. , 1991, The Journal of biological chemistry.
[49] S. Waxman,et al. Na+‐Ca2+ exchanger mediates Ca2+ influx during anoxia in mammalian central nervous system white matter , 1991, Annals of neurology.
[50] E. G. Jones,et al. Numbers and proportions of GABA-immunoreactive neurons in different areas of monkey cerebral cortex , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[51] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.